Assessing cancer risk in individuals
Official title: Prevent Cancer-Greenville: A Center for Cancer Prevention and Wellness Research Project
Run by Prisma Health-Upstate · NCT04947098 · Data updated 2026-11-12
This study is testing how personal history, lifestyle, and biological samples can help identify people at higher risk of developing cancer so they can get the right care.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 1000 (estimated) |
| Sponsor | Prisma Health-Upstate Academic / other |
| Locations | 1 site (Greenville, South Carolina) |
| Status | Recruiting |
| Started | November 8, 2018 |
| Main results expected | November 8, 2028 |
| Study ends | November 8, 2029 |
| Registry record updated | February 17, 2026 |
| Trial ID | NCT04947098 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are adults aged 18 years or older who are interested in understanding their cancer risk.
✕Probably not a fit
Patients who are not at risk for cancer or those who are under 18 years old may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Prevent Cancer-Greenville aims to evaluate individuals' risk of developing cancer based on personal history, lifestyle, and biological samples. Participants will undergo risk stratification to identify those at higher risk due to factors such as genetics, family history, and environmental exposures. The study involves yearly health assessments that measure nutrition, physical activity, and body composition. If participants are identified as high risk, they will be referred to healthcare providers for further evaluation and care.
Why it matters
Potential benefit: If successful, this study could help identify individuals at high risk for cancer, allowing for early intervention and preventive measures.
How similar studies have gone: Other studies focusing on cancer risk assessment and stratification have shown promise in identifying high-risk individuals and improving preventive care.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * 18 years or older
Where it's running
-
Prisma Health-Upstate
Greenville, South Carolina, United States Recruiting
Study contacts
- Principal investigator: Joe Stephenson, MD — Prisma Health-Upstate
- Study coordinator: Patricia Wilson, MSN Ed. OCN ONNCG
- Email: ccpw@prismahealth.org
- Phone: 864-455-4897
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Short-course radiotherapy plus intensified chemotherapy and targeted therapy with immunotherapy for high-risk rectal cancer
This trial tests whether adding targeted therapy and a PD-1 inhibitor to a short course of radiotherapy and standard chemotherapy helps high-risk pMMR/MSS rectal cancer patients, compared with the same radiotherapy and chemotherapy alone.
-
Performance analysis of an HPV test for anal cancer screening
This study is testing a new HPV test on anal samples to see if it can help high-risk people find anal cancer and precancerous conditions more easily.
-
Combining Toripalimab with Capecitabine for High-Risk Nasopharyngeal Carcinoma
This study is testing if combining toripalimab with capecitabine can help high-risk nasopharyngeal cancer patients avoid cancer coming back after their initial treatment.
-
Research on lung cancer screening behaviors and outcomes in high-risk individuals in Taiwan
This study looks at how high-risk individuals in Taiwan, like smokers or those with a family history of lung cancer, are getting screened for lung cancer using low-dose CT scans to see how effective these screenings are.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.